Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

FDA Clears IND for Be Bio’s Engineered B Cell Therapy in Hemophilia B

May 29, 2024

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought Leaders at MIT Koch Institute

May 28, 2024

Be Biopharma Announces FDA Clearance of IND Application for BE-101 in Hemophilia B

May 28, 2024

Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases

May 20, 2024

Progentos emerges with $65M for multiple sclerosis trials with IP from Frequency

May 20, 2024

The biotech news you need to read this morning

May 20, 2024
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved